Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
21,624,878
-
Share change
-
+17,458,579
-
Total reported value
-
$628,421,658
-
Price per share
-
$29.06
-
Number of holders
-
65
-
Value change
-
+$507,347,658
-
Number of buys
-
62
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q4 2017
As of 31 Dec 2017,
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,624,878 shares.
The largest 10 holders included
NEA Management Company, LLC, TRV GP, LLC, MPM ASSET MANAGEMENT LLC, BAKER BROS. ADVISORS LP, FMR LLC, JANUS HENDERSON GROUP PLC, PERCEPTIVE ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WELLINGTON MANAGEMENT GROUP LLP, and EcoR1 Capital, LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.